187 related articles for article (PubMed ID: 5260856)
21. [Prognostic factors in chronic myeloid leukemia. Apropos of 798 cases].
Jacquillat C; Chastang C; Bancalari G; Weil M; Bernard J
Ann Med Interne (Paris); 1975; 126(6-7):515-20. PubMed ID: 1065252
[No Abstract] [Full Text] [Related]
22. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
Preisler HD; Kirshner J
Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
[TBL] [Abstract][Full Text] [Related]
23. [Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
Masaoka T; Kimura K; Miyazaki T; Hirota Y; Nakamura T; Yasunaga K; Ohkubo H; Okamoto Y; Fujitake H; Kitani T
Gan To Kagaku Ryoho; 1985 May; 12(5):1111-8. PubMed ID: 3888116
[TBL] [Abstract][Full Text] [Related]
24. [Survival of 29 cases of chronic myeloid leukemia treated by myleran].
Petitclerc C; Barry A
Union Med Can; 1976 Feb; 105(2):210-6. PubMed ID: 1069396
[No Abstract] [Full Text] [Related]
25. [Survival in chronic myeloid leukemia following aplasia caused by Misulban].
Perreau P; Gardais J
Sem Hop; 1969 Mar; 45(15):964-70. PubMed ID: 4307171
[No Abstract] [Full Text] [Related]
26. Treatment of busulfan-induced pancytopenia.
Stuart JJ; Crocker DL; Roberts HR
Arch Intern Med; 1976 Oct; 136(10):1181-3. PubMed ID: 1067785
[TBL] [Abstract][Full Text] [Related]
27. [Early splenectomy in chronic granulocytic leukemia. 15 years' experience].
Avilés A; Ibarrola JL; Sigler L; Pizzuto J
Sangre (Barc); 1986; 31(6):677-84. PubMed ID: 3470954
[No Abstract] [Full Text] [Related]
28. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
29. [Observations on the terminal course of chronic myeloid leukemia treated by alkylating agents (busulfan)].
Giovanelli E
Minerva Med; 1970 May; 61(37):2038-41. PubMed ID: 4097050
[No Abstract] [Full Text] [Related]
30. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
Ball ED; Wilson J; Phelps V; Neudorf S
Bone Marrow Transplant; 2000 Apr; 25(8):823-9. PubMed ID: 10808202
[TBL] [Abstract][Full Text] [Related]
31. Blastic crisis of chronic myelogenous leukaemia.
Koza I; Cerný V; Bohunický L; Hal'ko J; Ujházy V; Petrek C; Krizan Z
Neoplasma; 1969; 16(4):417-26. PubMed ID: 5259327
[No Abstract] [Full Text] [Related]
32. Long-term follow-up of allogeneic marrow transplantation for acute myelogenous leukemia after treatment with busulfan and cyclophosphamide.
Bolaños-Meade J; Hartley E; Jones RJ
Biol Blood Marrow Transplant; 2006 Mar; 12(3):366-7. PubMed ID: 16503506
[No Abstract] [Full Text] [Related]
33. [Effect of patients' gender on the course of chronic myeloid leukemia].
Abdulkadyrov KM; Rukavitzyn OA; Bessmel'tsev SS; Lomtev AIu
Vopr Onkol; 1997; 43(3):290-4. PubMed ID: 9245084
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy of chronic myelocytic leukemia.
Galton DA
Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
[No Abstract] [Full Text] [Related]
35. [Continual and periodic treatment of patients with chronic granulocytic leukemia].
Colović M; Petrović M; Jancić MS; Banićević B; Vucić Lj; Janosević S; Ristić M
Srp Arh Celok Lek; 1984 Apr; 112(4):487-93. PubMed ID: 6595809
[No Abstract] [Full Text] [Related]
36. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
[TBL] [Abstract][Full Text] [Related]
37. Chronic granulocytic leukemia with lymphadenopathy and leukemia cutis.
Padmanabhan K; Subramanian R; Vaidyanathan CV
J Assoc Physicians India; 1982 Aug; 30(8):552-4. PubMed ID: 6963267
[No Abstract] [Full Text] [Related]
38. [Very long survivals of chronic granulocytic leukemia (author's transl)].
Debray J; Pommier Y; Audebert AA; Krulik M; Smadja N; Zylberait D
Sem Hop; 1980 Feb 18-25; 56(7-8):309-13. PubMed ID: 6246623
[TBL] [Abstract][Full Text] [Related]
39. [15 years experience in treating chronic myeloleukemia patients at a polyclinic].
Nevskaia TP
Gematol Transfuziol; 1984 Nov; 29(11):12-5. PubMed ID: 6597780
[No Abstract] [Full Text] [Related]
40. Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia.
Bolin RW; Robinson WA; Sutherland J; Hamman RF
Cancer; 1982 Nov; 50(9):1683-6. PubMed ID: 6956430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
